DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients

Featured

Want to learn more about DIA/FDA Advancing Complex Innovative Clinical Trial Designs to Efficiently Deliver Medicines to Patients? You've come to the right site!

Continuing Education

Robert A. Beckman, MD Professor of Oncology and of Biostatistics, Bioinformatics, and Biomathematics
Georgetown University Medical Center, United States
Fanni Natanegara, PhD Sr. Director, Global Statistical Sciences - Japan
Eli Lilly and Company, Japan
Zoran Antonijevic, MSc Vice President, Statistical Consulting
Abond CRO Inc., United States
Cristiana Mayer, DrSc, PhD Head of Biostatistics
Johnson & Johnson Vision, United States
Dionne Price, PhD Deputy Director, Office of Biostatistics, OTS, CDER
FDA, United States
Karen Lynn Price, PhD Senior Research Fellow, Statistical Innovation Center/Design Hub
Eli Lilly and Company, United States
Pritibha Singh, MBA, MSc Senior Manager, Corporate Affairs Analytics & Insights
Novartis AG, Switzerland
Rui (Sammi) Tang Vice President, Global Head of Biometrics
Servier Pharmaceuticals, United States
Amy Xia, PhD Vice President, Center for Design and Analysis
Amgen Inc., United States
Maria Apostolaros, JD, PharmD, MS, RPh Deputy Vice President, Science and Regulatory Advocacy
PhRMA, United States
Yi Liu, PhD Vice President, Biometrics
Nektar Therapeutics, United States